A 55-year-old female presented with a rare solitary plasmacytoma restricted to the skull vault without systemic myelomatosis. She had a 9-month history of a slowly growing soft mass in the right temporal region. Neuroradiological examination revealed a skull defect and an extradural tumor. The whole lay er of the skull was destroyed by the tumor, but the dura was not involved. The tumor was totally re moved, and postoperative radiotherapy was given. Follow-up examination after 2 years showed she was free from local recurrence or evidence of systemic involvement. Complete surgical resection with adjuvant radiation therapy is the treatment of choice. Although the prognosis is good, regular life long examinations for myelomatosis are required.
Introduction
Plasmacytoma of the skull is usually a manifestation of systemic myelomatosis or multiple myeloma, and occurs as multiple lesions. Solitary lesions are not un usual in the skull, but usually occur in systemic my elomatosis. 3,5,7,s,16,22) True solitary plasmacytomas of the skull vault without signs of systemic myelo matosis are very rare, with only about 20 such cases reported .2,1,2') This excludes plasmacytomas in volving the skull base since lesions originating from the nasopharynx, oropharynx, or paranasal sinuses, which are defined as extramedullary plasmacyto mas,22) often invade the skull base secondarily, 10 and are difficult to differentiate from true skull plasmacy tomas. Furthermore, lesions infiltrating the skull base are unlikely to be solitary and carry a high risk of progression to multiple myeloma.4) In contrast, the prognosis for solitary plasmacytoma of the skull vault is good when there is no evidence of systemic myelomatosis.
Some authors',') say that postopera tive radiotherapy is not required when the tumor is completely resected, although it is given in most cases.
We describe a patient with a solitary plasmacyto ma of the skull treated by surgery.
Case Report
A 55-year-old female first noted a painless, soft swell ing in the right temporal region in October 1992. The swelling progressively grew and became slightly ten der in June 1993. A skull tumor was diagnosed at a local hospital and she was transferred to our clinic in July 1993. Physical examination found a soft swelling, 7 x 5 cm, in the right temporal region extending to the lateral supraorbital region, with normal overlying skin. Neurological examination found no abnormali ties. Computed tomography (CT) showed a large ex tradural mass in the right temporal region, with homogeneous enhancement except for a small por tion in the center after intravenous administration of contrast material (Fig. 1) . Bone window CT dis closed a lytic lesion involving the whole layer of the skull. The inner and outer tables were partly pushed apart at the edge of the defect (Fig. 2) . Magnetic resonance (MR) imaging showed that the mass was mostly isointense with the brain parenchyma on both T1 and T2-weighted images and homogeneously enhanced by gadolinium-diethylenetriaminepenta acetic acid (Gd-DTPA), except for a small area in the center of the mass which was hypointense on both T, and T2-weighted images. There was a line of low signal intensity between the tumor and the brain on the T2-weighted image, indicating that the dura had prevented tumor invasion of the brain (Fig. 3) . Chest radiographs revealed no pathological findings. Neither bone scintigraphy using technetium-99m hydroxy methylene diphosphonate nor gallium-67 citrate scintigraphy showed any hot spots through out the body. Cerebral angiography showed a marked tumor stain which was fed by the middle meningeal and accessory meningeal arteries (Fig. 4  left) .
Laboratory examinations found red blood cell count of 4.38 x 106/mm3, hemoglobin 13.5 g/dl, white blood cell count 3700/mm3, platelet 203,000/ mm3, total serum protein 7.0 g/dl, globulin 2.91 g/ dl, gamma globulin 13.5%, serum calcium 9.3 mg/ dl, and serum phosphorus 4.0 mg/dl, which were all within the normal range. Other serum electrolytes were also within the normal range. Only alkaline phosphatase, 178 IU/1, was above the normal limit of 125 IU/1. The immunoelectrophoresis of serum proteins showed normal levels of immunoglobulins (Igs) with IgG 1350 mg/dl, IgA 161 mg/dl, and IgM 230 mg/dl. A urine test for Bence Jones protein was negative. Bone marrow aspiration revealed no evi dence of systemic myelomatosis. Tumor markers such as carcinoembryonic antigen, alpha fetoprotein, and carbohydrate antigens 19-9 and 125, and squamous cell carcinoma-related antigen were all within the normal range.
The feeding arteries were successfully embolized using polyvinyl alcohol and Hilal MicrocoillM (COOK Inc., Bloomington, Ind., U.S.A.) on August 11. The tumor stain disappeared almost completely (Fig. 4 right) . She underwent a frontoparietotem poral craniotomy on August 18. The tumor was en capsulated, and there was no adhesion to the over lying skin and temporal muscle. The yellowish tu mor was soft and partly elastic, and easily separat ed from the dural surface. The dura was left intact. Bleeding from the tumor was minimal. The frontal sinus was destroyed in the right upper corner, but the mucous membrane inside was intact. The later al part of the orbital roof was also destroyed, but the periorbital membrane remained intact. The skull defect was sharply demarcated and there was no osteoplastic reaction along the edge. The bone detect was widened to ensure the complete removal of the tumor. The skull defect was reconstructed us ing the inner table separated from the parietal bone flap. The outer table was returned to the parietal defect. Histological examination of the specimen showed plasmacytoma. The cells were stained for Ig kappa light chain, but not for lambda light chain (Fig. 5) .
She received a postoperative radiotherapy of 50 Gy and was discharged without neurological deficit. At the follow-up examination 2 years after the opera tion, she was doing well. MR imaging showed no sign of local recurrence. The systemic bone scinti gram was negative. She had no anemia, and im munoelectrophoresis of serum proteins showed a nor mal pattern.
Serum electrolytes were within normal limits, with normalization of alkaline phosphatase.
The urine test for Bence Jones protein was negative. 
Discussion
Previous cases of solitary plasmacytomas of the bone have arisen from within the diploic space and expanded in both directions .2,9,21) Typically patients presented with a painless growing tumor, and nor mal skin overlying the mass. The tumor may ex tend subperiosteally, not involving the galea.2) Diagnostic criteria include: a radiologically solitary lesion, histological confirmation, negative bone mar row examination, negative immunoelectrophoresis, negative urine test for Bence Jones protein, no evidence of hyperglobulinemia, and absence of ane mia. 3,12,13> Furthermore, there should be no labora tory or radiological evidence of systemic dissemina tion for 2-3 years following the initial diagno sis.',") The present case meets all these criteria. The diagnosis of solitary plasmacytoma can never be ab solutely certain on the basis of examination of bone marrow.
Bone marrow involvement in multiple myeloma may be patchy, and the specimen may be taken from a section not involved by the disease. or in which the tumor was not completely re moved.') On the other hand, complete resection of solitary plasmacytoma of the skull without adju vant radiotherapy has lead to multiple bone metas tasis 3 years later.") Although the tumor was totally removed, our patient received 50 Gy irradiation to be on the safe side. Since patients receiving 30 Gy or less have suffered local recurrence, a dose of 40-60 Gy is recommended,', ",'0) but local recurrences or metastasis have occurred even with higher doses.') The efficacy of chemotherapy for this tumor is not certain. Chemotherapy with melphalan, cyclophos phamide, vincristine, vindesine, adriamycin, or prednisolone alone or in combination has failed to provide any benefit to patients.8,16) Multiple bone involvement requires systemic chemotherapy, but protracted courses of chemotherapy should be avoided in patients with solitary plasmacytoma of bone who have the potential for long-term survival because of the high incidence of therapy-related acute leukemia.') Solitary plasmacytomas of the cranial vault are characterized by a good prognosis, if there is no evi dence of systemic involvement.',") Nevertheless, there is a possibility of dissemination years later, so regular follow-up examinations for myelomatosis are required.9,"
